First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses (Q33858229)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

0 references

multicenter clinical trial

0 references

phosphatidylcholine

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

ulcerative colitis

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Wolfgang Stremmel

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Stefan Schreiber

4

object named as

Stefan Schreiber

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Max Karner

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Andreas Kocjan

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Georg von Boyen

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Peter Uebel

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Carsten Schmidt

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Limas Kupcinskas

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Ion Dina

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Frank Zuelch

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Gerhard Keilhauer

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

0 references

publication date

6 May 2014

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

109

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1041-1051

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

Anti-inflammatory effects of phosphatidylcholine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

Cyclosporine A for induction of remission in severe ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

Inflammatory Bowel Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

A simple clinical colitis activity index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

The hydrophobic barrier properties of gastrointestinal mucus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

Intestinal surfactant-like material. A novel secretory product of the rat enterocyte

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

28 July 2018

Serious events with infliximab in patients with inflammatory bowel disease: a 9-year cohort study in the Netherlands.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.104

21 January 2018

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.104

21 January 2018

Reduced hydrophobicity of the colonic mucosal surface in ulcerative colitis as a hint at a physicochemical barrier defect.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.104

21 January 2018

Phospholipid in UC: novel, safe and works--is it too good to be true?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.104

21 January 2018

Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.104

21 January 2018

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.104

21 January 2018

Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis--a review of three clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

29 October 2018

Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

29 October 2018

Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

29 October 2018

Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

29 October 2018

Defining relapse of ulcerative colitis using a symptom-based activity index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085478

29 October 2018

Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24796768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24796768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The quantitative validation of non-endoscopic disease activity indices in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24796768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is endoscopy necessary for the measurement of disease activity in ulcerative colitis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24796768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/24796768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/24796768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/AJG.2014.104

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24796768%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33858229&oldid=2098610947"